Matches in Wikidata for { <http://www.wikidata.org/entity/Q66398299> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66398299 description "clinical trial" @default.
- Q66398299 description "ensayu clínicu" @default.
- Q66398299 description "klinisch onderzoek" @default.
- Q66398299 description "клінічне випробування" @default.
- Q66398299 name "GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3" @default.
- Q66398299 name "GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3" @default.
- Q66398299 type Item @default.
- Q66398299 label "GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3" @default.
- Q66398299 label "GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3" @default.
- Q66398299 prefLabel "GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3" @default.
- Q66398299 prefLabel "GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3" @default.
- Q66398299 P1132 Q66398299-414EE150-66B3-4C72-BC64-3D96B595EDC5 @default.
- Q66398299 P1476 Q66398299-031A3741-40EC-4DFD-A17D-FBA8698A6113 @default.
- Q66398299 P17 Q66398299-186377C5-E31A-4D69-9C54-3D1D58947365 @default.
- Q66398299 P17 Q66398299-21C16B53-04D6-4FEB-AED9-3D2B09F77975 @default.
- Q66398299 P17 Q66398299-29AC3446-467F-4510-8B48-C2A25EBFCF92 @default.
- Q66398299 P17 Q66398299-A9D2472B-D578-49AB-B161-F0A70952DED4 @default.
- Q66398299 P1813 Q66398299-E2C392C1-4E6F-4DC7-AAEC-26AD716BD08F @default.
- Q66398299 P2899 Q66398299-F79543C3-45D1-42A8-A88D-290637492E99 @default.
- Q66398299 P3098 Q66398299-932B67F6-9315-43BE-9EB4-FAE8C8AC49E8 @default.
- Q66398299 P31 Q66398299-671AD4F5-6A96-403D-AD49-53FDF359296C @default.
- Q66398299 P580 Q66398299-A857EF88-FA06-4CB7-9D7A-CD1479A2F8CE @default.
- Q66398299 P582 Q66398299-13F25CB5-8EBC-4017-85DF-BCFBEF9D1ACC @default.
- Q66398299 P6099 Q66398299-AF64BC57-7542-4D1E-B47A-DA67DF98BB23 @default.
- Q66398299 P8363 Q66398299-EF215362-773E-4FB9-B9E4-2474DE587CE0 @default.
- Q66398299 P1132 "+10" @default.
- Q66398299 P1476 "A 52-week Two-part, Open-label, Multicenter, Multinational Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3" @default.
- Q66398299 P17 Q145 @default.
- Q66398299 P17 Q17 @default.
- Q66398299 P17 Q183 @default.
- Q66398299 P17 Q30 @default.
- Q66398299 P1813 "LEAP" @default.
- Q66398299 P2899 "+18" @default.
- Q66398299 P3098 "NCT02843035" @default.
- Q66398299 P31 Q30612 @default.
- Q66398299 P580 "2017-01-04T00:00:00Z" @default.
- Q66398299 P582 "2023-10-01T00:00:00Z" @default.
- Q66398299 P6099 Q42824440 @default.
- Q66398299 P8363 Q78089383 @default.